India's Healthcare Industry :Innovation in Delivery, Financing, and Manufacturing

Publication subTitle :Innovation in Delivery, Financing, and Manufacturing

Author: Lawton R. Burns  

Publisher: Cambridge University Press‎

Publication year: 0000

E-ISBN: 9781316020975

Subject: F27 Enterprise Economy

Keyword: 企业经济Enterprise Economy

Language: ENG

Access to resources Favorite

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

India's Healthcare Industry

Description

This book analyzes the historical development and current state of India's healthcare industry. It describes three sets of institutions that deliver healthcare services, finance these services, and manufacture products used in these services. These institutions provide healthcare (hospitals, physicians, pharmacies, and diagnostic laboratories), pay for healthcare (individuals who pay out-of-pocket, insurance companies, community insurance schemes, government ministries) and produce the technology used in healthcare delivery (pharmaceuticals, biotechnology, and medical devices). The volume also discusses innovative efforts to raise capital for the development of these sectors. Finally, it includes three interesting case studies of innovative models of healthcare delivery (L. V. Prasad, Aravind, and Vaatsalya), as well as analyses of other innovative organizations like Narayana Hrudaylaya and the hospital chains. The contributors to the volume include Wharton faculty members, graduates of Wharton's healthcare MBA program, and executives and consultants from India.

Chapter

Healthcare goals of India

Economic impact of the state of health

The public face of the healthcare system

Challenges in healthcare

Continuing burden of infectious diseases

The situation

Innovative interventions

Business and organizational challenges

Reproductive and child health and nutrition

The situation

Innovative interventions

Business and organizational challenges

Chronic diseases and injuries

The situation

Innovative interventions

Business and organizational challenges

Healthcare human resources

The situation

Innovative interventions

Business and organizational challenges

Healthcare finance

The situation

Innovative interventions

Business and organizational challenges

Access to care and health equity

The situation

Innovative interventions

Business and organizational challenges

Conclusion

Notes

3 India’s Healthcare Industry: An Overview of the Value Chain

Introduction

Public administration and policy

Central versus state government responsibilities

Levels of governmental administration

Government roles in healthcare: Payer and provider

Evolution of health policy

Healthcare financing

Aggregate analysis

Historical trends

Sources and destinations of funding

Sources

Destinations

Out-of-pocket spending

Governmental allocations: R&D investments and vertical disease programs

Other sources of financing: public–private partnerships and private equity

Structure of healthcare delivery

Levels of care: Primary, secondary, tertiary

Primary care

Secondary and tertiary care

Geographic locale: rural versus urban

Rural India

Urban India

Ownership: Public versus private

Growth of the private sector and corporate hospitals

New delivery models

Manpower and human resource issues

Manpower levels and distribution

Manpower shortages

Causes of manpower shortages

Possible solutions to the manpower shortage

Rise of health insurance

History

Coverage

Healthcare technology

Pharmaceutical and life sciences sector

Brief history of the pharmaceutical sector

Recent achievements of the sector

Financing of drug expenditures

Efforts to rein in drug expenditures

Wholesale and retail pharmacy

Outsourcing and clinical research

Biotechnology sector

Medical device and equipment sector

Growth drivers of the technology sectors

Healthcare regulation

Governmental role in healthcare: Regulator

Five-Year Plans

Governmental bureaucracy and regulatory ineffectiveness

Regulation and conflicts of interest

Regulation and pharmaceuticals

NRHM coordination with local government

Public health

Conclusion

Notes

Section II PROVIDERS: Delivery of Healthcare Services

4 The Medical Profession in India

Introduction

Medical practitioner supply

Physician emigration: “The doctor is out”

Increasing career prospects in nonmedical sectors

Medical college supply

Background

Regulatory challenges to new school construction and physician recruitment

Central government obstacles

Medical college expansion in the 1990s

Geographic variation in medical college supply

Charges of commercialization and corruption

Commercialization of medical education

Alleged corruption in medical education

Becoming a physician in India

Practicing as a physician in India

Primary care versus speciality practice

Private practice characteristics

How different stakeholders deal with physicians

Hospitals

Pharmaceutical and device manufacturers

Governments

Important trends influencing the medical profession

Rapid economic growth

Healthcare infrastructure build-up

Chronic diseases

Health insurance

The influence of mobile and other technologies

Globalization and offshoring

Notes

5 India’s Hospital Sector: The Journey from Public to Private Healthcare Delivery

Introduction

Rising demand and imbalance with supply

Addressing the imbalance: Causes and solutions

Clinical right-siting of care

Geographic right-siting

Economic right-siting

The public healthcare system

Policy

Gap between policy aims and achievements

Innovation in the public sector

Health ship

Tribal treatment centers

Low-cost diagnostics

The private healthcare system

Background

Policy

Private equity funding

Registration and accreditation

Low-cost innovative models in the private sector

Vaatsalya

Narayana Hrudayalaya

Background

Unique approach and media attention

A city of focused factories

Business model

Future growth

Is Narayana scalable or replicable?

Major private hospital systems

Fortis Healthcare

History

Organizational model

Operating system

Physician engagement model

Challenges with hospital operations

Vertical integration redux

Apollo Hospitals

History

Growth strategy

Diversification

Integrated system

Serving the bottom of the pyramid

Business model

Physician engagement model

Challenges going forward

Max Healthcare

History and growth

Business model

Future strategic efforts and challenges

Future outlook

Notes

6 Medical Tourism: Opportunities and Challenges

Introduction

Trade in healthcare services

Benefits and risks of trade

Medical tourism market size

Estimates of Mode 2 exports and imports

Estimates of US medical tourism patient and revenue volumes

The search for value

Customer segments and value proposition

Profile of medical tourists

Supply and demand factors in medical tourism

The consumer experience in medical tourism: Integrated care

Sources of value

Sources of lower-cost care abroad

Comparable quality: Getting Harvard healthcare in Dubai

The emerging role of the payer

Availability of insurance coverage for healthcare abroad

Incentives and interests of payers to get involved

Cost savings: Win-win-win for individuals, employers, and payers

Medical tourism and current state of private payers

Barriers to payer involvement in medical tourism

Payer interests in overseas coverage in the interim

Consumerism and medical tourism: Synergistic trends

Concerns to be addressed or considered

Comparable quality of care

Follow-up care

Malpractice and liability

Truth in advertising

Medical tourism opportunity in India

Medical tourism capabilities

Focused hospital initiatives

Focused government initiatives

Can disrupted innovation itself be disrupted?

Disruption by health cities in the Western hemisphere

Disruption by healthcare reform in the US

Notes

Appendix: Quality Standards and Performance of Indian Hospitals

Introduction

Quality standards in the Indian public health system

The paradox of quality medical care in the Indian private sector

Quality standards and organizations

ISO certification

National Accreditation Board for Hospitals (NABH)

Patient-centered standards

Organization-centered standards

Joint Commission International (JCI)

Section I: Patient-centered standards

Section II: Health care organization management standards

The financial model as driver of medical quality

Consumer-centered experience

Management structure

Leadership

Tiered pricing

Reverse engineering

Cost drivers

Telemedicine

Data analysis

Notes

7 The Aravind Eye Care System

Introduction

Why the eye?

Aravind’s growth and performance drivers

Volume

Model of care

Financial sustainability

Quality

Operational efficiency

Clinical spectrum and comprehensive eye care

Organizational capabilities

Manufacturing

Research

Consulting

Education

Summary

General applicability of the Aravind model

Can others replicate Aravind’s success?

Can Aravind replicate itself?

Strategic analysis of Aravind

Strengths

Market share

Brand

Focused business model

Operational efficiency and history

Culture

Weaknesses

Threats

Disruptive innovation

Corporate culture

Competition

Government involvement in healthcare

Opportunities

Geographic expansion

Capability expansion

Medical tourism

Practice model evolution

Conclusion

Notes

8 The Real Deal at L V Prasad Eye Institute: Excellence and Equity in Healthcare

Introduction: an LVPEI experience

Healthcare and eye care in India

Overview

Eye care overview

Accessibility

Affordability

The LVPEI model

The Aravind model

Sankara Eye hospitals

Sankara Nethralaya

The LVPEI story

Mission of excellence, efficiency, and equity

Humble beginnings of a grand vision

A dream come true

The arms of LVPEI

Organizational structure

Clinical care

Public health and community eye health

Rehabilitation

Education

Research

Eye bank

Financial review: Inflows and outflows

Sources of funds

Expenditures/destinations of funds

Financial performance

Sustainability – making every rupee count

Strategic assessment: Opportunities and threats

Expansion and replication

Human resources

Competition

LVPEI going forward

Growth trajectory

Evolution of management

Conclusion

Appendix: Discussion questions

Notes

9 Vaatsalya Healthcare: Promoting Access to Healthcare in Rural and Semi-Urban India

Introduction

Primary evidence on lack of access to low-cost care

The Vaatsalya model

History, financing, and growth

New business development: how Vaatsalya selects location and service offerings

Attracting and retaining qualified clinical staff

Physician recruitment and compensation

Nursing and clinical assistant recruitment and compensation

Maintaining low-cost operations

Quality improvement and expansion plans

Current challenges to growth

Conclusion

Notes

Section III PAYERS: Financing of Healthcare Services

10 The Health Insurance Sector in India: History and Opportunities

Introduction

Benefits of insurance

Health insurance 101

Employer-level issues

Individual-level issues

Insurance company-level issues

Insurance market failures

The health insurance landscape in India

Early history of insurance

Regulatory changes

Market trends

Current insurance coverage landscape

Employer-sponsored and wage-based insurance

Private insurance

Catastrophic insurance schemes for the poor

Community-based insurance

Challenges and future directions

Challenges

Future directions

Notes

11 Providing Care to the Bottom of the Pyramid

Bottom of the pyramid (BOP) defined

Demographic profile of the BOP population

Health status

Public health structure

Rural public health infrastructure

Ineffectiveness of rural public health

Urban public health infrastructure

Ineffectiveness of urban public health

Public policy

Recent policy initiatives

Private healthcare

Registered medical practitioners and quacks

Nongovernmental organizations (NGOs)

Other for-profit providers

Models that work

Yeshasvini health insurance scheme

Access

Quality

Cost

Narayana Hrudayalaya hospital group

Access

Quality

Cost

Acumen Fund: Healthcare financing

Conclusion

Notes

12 Opportunities in Healthcare Private Equity in India

Introduction

Definitions

History of PEVC in India

Phase 1 (1988–94)

Phase 2 (1995–99)

Phase 3 (2000–2010)

Phase 4 (2011–present)

Current market dynamics

Key players and their strategies

ICICI Ventures

Baring Private Equity Partners (BPEP)

Religare

Kotak Private Equity Group (KPEG)

CX Partners

Trends impacting healthcare opportunities in India

Investment opportunities

Hospital infrastructure

Health insurance

Mobile health (mHealth)

Diagnostic laboratories

Telemedicine

Contract research organizations (CROs)

Future prospects and barriers

Notes

Section IV PRODUCERS: Manufacturers of Healthcare Technology

13 The Indian Pharmaceutical Sector: The Journey from Process Innovation to Product Innovation

Overview

History of India’s pharmaceutical sector

Description of the Indian pharmaceutical market

Therapeutic areas

The fragmented domestic market

Foray of Indian pharmaceutical companies into global markets

Development of the US generics market

Key drivers, trends, and areas of growth

A growing middle class and rising disposable income drive domestic consumption

Growing infrastructure and insurance drive domestic growth

Indian companies’ pursuit of inorganic growth

Japan’s emergence as an attractive market for generics

Indian companies’ collaboration with global MNCs

Indian pharmaceutical firms’ heavy investment in biosimilar development

Leading Indian pharmaceutical companies

Ranbaxy Laboratories (1961)

Recent events, opportunities, and concerns

Dr Reddy’s Laboratories (1984)

Key highlights of DRL’s current empire

Recent events, opportunities, and concerns

Sun Pharmaceuticals (1983)

Recent events, opportunities, and concerns

Lupin (1968)

Key highlights of Lupin’s current empire

Recent events, opportunities, and concerns

Cipla Pharmaceuticals (1935)

Recent events, opportunities, and concerns

Global MNCs increase stake in Indian pharmaceutical sector through M&A

The India advantage: Costs and resources

Manufacturing cost

Existing infrastructure

Talent

Patent landscape in India

The Indian drug regulatory system

Economics and pricing of expensive drugs

Pharmaceutical innovation

Conclusion

Notes

14 India’s Biotechnology Sector

Market overview

Biopharmaceuticals

Vaccines

Diagnostics

Therapeutics

Bioservices

Domestic biotechnology company profiles

Biocon

Recent events

Serum Institute of India

Recent events

Panacea Biotec

Recent events

Government policy

Regional biotechnology development

Financing environment

International partnerships as a funding source

Conclusion

Notes

15 The Medical Device Sector in India

Introduction: What are medical devices?

Summary of the global market

Overview of the Indian market

Market size and market segments

Market growth and drivers

Foreign versus domestic medical device manufacturers

Urban versus rural markets

Inefficiencies in medical device and equipment use

Diagnostic laboratories

Distinguishing customers, payers, and consumers

Technological innovation

Innovation strategies

Reverse innovation

Local innovators and “frugal innovation”

Financing of medical device innovation

Venture capital, socially conscious funds, and individual and institutional investors

Government sources of funding

Investments by large medical device companies/joint ventures

Incubators/accelerators

Capital markets

Regulation and reimbursement

Duties

Going forward

Notes

16 Balancing Access and Innovation in Developing Countries

Introduction

General determinants of competitiveness

Overview of the global medical device and technology sector

Dynamics of medical technology sector: lessons for developing markets

Segmentation of healthcare product choice, access, and financing

Aggregation strategy

Adaptation strategy

Benefits of medical technology innovation

Challenges and opportunities in accessing medical technology

Developments in reimbursement and health insurance in India

The role of infrastructure

Concluding observations on scalable and sustainable innovation in India

Notes

Contributors

Index

The users who browse this book also browse